SLC25A26
Basic information
Region (hg38): 3:66133610-66388116
Links
Phenotypes
GenCC
Source:
- combined oxidative phosphorylation deficiency 28 (Strong), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 28 (Supportive), mode of inheritance: AR
- combined oxidative phosphorylation deficiency 28 (Strong), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 28 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Neurologic | 26522469 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A26 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 12 | ||||
missense | 32 | 40 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 10 | 1 | 12 | ||
non coding | 53 | 49 | 67 | 169 | ||
Total | 1 | 2 | 87 | 65 | 72 |
Highest pathogenic variant AF is 0.0000132
Variants in SLC25A26
This is a list of pathogenic ClinVar variants found in the SLC25A26 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-66220525-G-C | Benign (Jun 14, 2018) | |||
3-66220535-C-T | Benign (Jun 14, 2018) | |||
3-66220543-G-A | Benign (Jun 14, 2018) | |||
3-66220743-T-A | Benign (Jun 14, 2018) | |||
3-66220821-C-G | Benign (Jun 14, 2018) | |||
3-66220872-C-A | Benign (Sep 18, 2018) | |||
3-66220897-C-G | Likely benign (Aug 14, 2018) | |||
3-66220945-G-T | Likely benign (Jul 27, 2018) | |||
3-66221047-C-T | Likely benign (Jun 16, 2018) | |||
3-66221082-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
3-66221098-G-T | Inborn genetic diseases | Uncertain significance (Aug 12, 2022) | ||
3-66221127-G-A | Likely benign (Aug 27, 2020) | |||
3-66221128-G-A | Combined oxidative phosphorylation deficiency 28 | Likely pathogenic (Oct 26, 2022) | ||
3-66221164-C-T | Benign (Jun 14, 2018) | |||
3-66221175-C-T | Likely benign (Jan 23, 2020) | |||
3-66221177-T-C | Benign (Jun 16, 2018) | |||
3-66221191-C-C | Benign (Jun 14, 2018) | |||
3-66221319-C-T | Likely benign (Jun 29, 2019) | |||
3-66221358-G-G | Benign (Jun 14, 2018) | |||
3-66236234-G-A | Benign (Jun 14, 2018) | |||
3-66236253-G-A | Benign (Jun 16, 2018) | |||
3-66236273-T-G | Likely benign (Jul 26, 2019) | |||
3-66236324-A-G | Likely benign (Aug 17, 2018) | |||
3-66236384-G-A | Benign (Jun 14, 2018) | |||
3-66236407-G-T | Benign (Jun 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A26 | protein_coding | protein_coding | ENST00000354883 | 10 | 319256 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.58e-7 | 0.507 | 125553 | 0 | 40 | 125593 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.391 | 144 | 131 | 1.10 | 0.00000635 | 1711 |
Missense in Polyphen | 41 | 39.812 | 1.0298 | 499 | ||
Synonymous | 0.511 | 45 | 49.6 | 0.908 | 0.00000243 | 558 |
Loss of Function | 0.870 | 12 | 15.7 | 0.763 | 7.96e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000390 | 0.000386 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000222 | 0.000218 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000192 | 0.000176 |
Middle Eastern | 0.000222 | 0.000218 |
South Asian | 0.000100 | 0.0000980 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial solute carriers shuttle metabolites, nucleotides, and cofactors through the mitochondrial inner membrane. Specifically mediates the transport of S- adenosylmethionine (SAM) into the mitochondria. {ECO:0000269|PubMed:14674884, ECO:0000269|PubMed:26522469}.;
- Pathway
- Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Methionine and cysteine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0908
Intolerance Scores
- loftool
- 0.693
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.100
- hipred
- N
- hipred_score
- 0.255
- ghis
- 0.508
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0167
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a26
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- ion transport;S-adenosyl-L-methionine transport;S-adenosyl-L-methionine transmembrane transport
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- S-adenosyl-L-methionine transmembrane transporter activity